Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Late peritoneal relapse of endometrial carcinoma: a case report
1Department of Obstetrics and Gynecology, Hyogo Prefectural Amagasaki General Medical Center, 660-8550 Amagasaki, Japan
DOI: 10.31083/j.ejgo.2021.02.2274 Vol.42,Issue 2,April 2021 pp.375-378
Submitted: 19 October 2020 Accepted: 08 December 2020
Published: 15 April 2021
*Corresponding Author(s): Hiroshi Sato E-mail: shiro801219@yahoo.co.jp
Late relapse of endometrial carcinoma occurring more than 10 years after the initial treatment is rare. Laparoscopic resection of such a late recurrent lesion has not been reported to the best of our knowledge. We herein report a case of successful laparoscopic management of a late peritoneal relapse of endometrial carcinoma in a postmenopausal 77-year-old woman. At 67 years of age, she had undergone initial surgery with adjuvant chemotherapy. At a routine visit after treatment of her cancer, computed tomography revealed an enhanced heterogeneous solitary mass at the right paracolic gutter. The mass was laparoscopically resected sparing there section of other organs. This case study demonstrates that for successful and definitive treatment of endometrial carcinoma, it is important to detect potentially recurring lesions through regular surveillance and as early as possible after the initial treatment. In addition, when treating late recurrent endometrial cancer, laparoscopic surgery is useful not only for exploration of the abdominal cavity but also for resection of the tumor.
Endometrial carcinoma; Laparoscopy; Late relapse
Miho Masuda,Hiroshi Sato,Takahiro Ozaki,Katsunori Matsui,Sayuri Miyoshi,Yu Takaishi,Saori Tsuji,Tomohiko Takei,Tatsuro Horiuchi,Makiko Ikeda,Miki Yasuda,Hajime Morishita,Yukiko Ando,Kenji Oida,Nao Taguchi,Masaya Hirose. Late peritoneal relapse of endometrial carcinoma: a case report. European Journal of Gynaecological Oncology. 2021. 42(2);375-378.
[1] Lederman GS, Niloff JM, Redline R, Rosen EM. Late recurrence in endometrial carcinoma. Cancer. 1987; 59: 825–828.
[2] Yechieli R, Robbins JR, Schultz D, Munkarah A, Elshaikh MA. Vaginal recurrence more than 17 years after hysterectomy and adjuvant treatment for uterine carcinoma with successful salvage brachytherapy: a case report. Case Reports in Oncology. 2011; 4: 242–245.
[3] Lorenz U, Gassel AM, Thiede A, Gassel HJ. Endometrial carcinoma recurrence in an abdominal scar 14 years after total hysterectomy. Gynecologic Oncology. 2004; 95: 393–395.
[4] Tsurumaki Y, Kume H, Homma Y. Late recurrence of uterine endometrioid carcinoma in the upper urinary tract. Archives of Gynecology and Obstetrics. 2009; 280: 631–632.
[5] Kim A, Nguyen L, Kalir T, Chuang L. Pelvic recurrence of stage 1A well-differentiated endometrial carcinoma after 13 years: a case report. Journal of the Turkish German Gynecological Association. 2016; 17: 51–54.
[6] Gallotta V, Nero C, Callari C, Lodoli C, Fanfani F, Fagotti A, et al. Laparoscopic management of a small bowel recurrence of endometrial cancer. Journal of Minimally Invasive Gynecology. 2016; 23: 160.
[7] Connor JP, Andrews JI, Anderson B, Buller RE. Computed tomography in endometrial carcinoma. Obstetrics & Gynecology. 2000; 95: 692–696.
[8] Koh W, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Chan J, et al. Uterine neoplasms, version 1.2014. Journal of the National Comprehensive Cancer Network. 2014; 12: 248–280.
[9] Ueda Y, Enomoto T, Egawa-Takata T, Miyatake T, Yoshino K, Fujita M, et al. Endometrial carcinoma: better prognosis for asymptomatic recurrences than for symptomatic cases found by routine follow-up. International Journal of Clinical Oncology. 2010; 15: 406–412.
[10] Seagle BL, Alexander AL, Lantsman T, Shahabi S. Prognosis and treatment of positive peritoneal cytology in early endometrial cancer: matched cohort analyses from the National Cancer Database. American Journal of Obstetrics and Gynecology. 2018; 218: 329.e1–329.e15.
[11] Matsuo K, Yabuno A, Hom MS, Shida M, Kakuda M, Adachi S, et al. Significance of abnormal peritoneal cytology on survival of women with stage I–II endometrioid endometrial cancer. Gynecologic Oncology. 2018; 149: 301–309.
Top